<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>2019 Archives - Global NIPT Consortium</title>
	<atom:link href="https://niptconsortium.com/category/2019/feed/" rel="self" type="application/rss+xml" />
	<link>https://niptconsortium.com/category/2019/</link>
	<description>Noninvasive Prenatal Testing (NIPT) Consortium</description>
	<lastBuildDate>Thu, 30 Nov 2023 18:25:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands</title>
		<link>https://niptconsortium.com/trident-2-national-implementation-of-genome-wide-non-invasive-prenatal-testing-as-a-first-tier-screening-test-in-the-netherlands/</link>
		
		<dc:creator><![CDATA[NIPTadmin]]></dc:creator>
		<pubDate>Sun, 01 Dec 2019 02:10:30 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[Clinical Experience / Clinical Utility]]></category>
		<category><![CDATA[CNVs]]></category>
		<category><![CDATA[Netherlands]]></category>
		<category><![CDATA[RAAs]]></category>
		<guid isPermaLink="false">https://niptconsortium.com/?p=9698</guid>

					<description><![CDATA[<p>van der Meij KRM, Sistermans EA, Macville MVE, et al. Am J Hum Genet. 2019;105(6):1091-1101. doi:10.1016/j.ajhg.2019.10.005. Open Access: Learn more Tags: Clinical Experience / Clinical Utility, 2019, Netherlands, RAAs, CNVs This publication describes results from a nationwide implementation study in the Netherlands that examined the use of NIPT as a first-tier test offered to all [&#8230;]</p>
<p>The post <a href="https://niptconsortium.com/trident-2-national-implementation-of-genome-wide-non-invasive-prenatal-testing-as-a-first-tier-screening-test-in-the-netherlands/">TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>van der Meij KRM, Sistermans EA, Macville MVE, et al. Am J Hum Genet. 2019;105(6):1091-1101. doi:10.1016/j.ajhg.2019.10.005. Open Access: <a href="https://www.cell.com/ajhg/fulltext/S0002-9297(19)30393-3" target="_blank" rel="noopener">Learn more</a></p>
<p><strong><em>Tags:</em></strong><em> Clinical Experience / Clinical Utility, 2019, Netherlands, RAAs, CNVs</em></p>
<ul>
<li>This publication describes results from a nationwide implementation study in the Netherlands that examined the use of NIPT as a first-tier test offered to all pregnant women, with the option to have findings beyond trisomies 21, 18, and 13 reported based on patient request. 78% of pregnant women chose to have these additional findings reported to them.</li>
</ul>
<p>The post <a href="https://niptconsortium.com/trident-2-national-implementation-of-genome-wide-non-invasive-prenatal-testing-as-a-first-tier-screening-test-in-the-netherlands/">TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing</title>
		<link>https://niptconsortium.com/noninvasive-prenatal-testing-for-fetal-subchromosomal-copy-number-variations-and-chromosomal-aneuploidy-by-low-pass-whole-genome-sequencing/</link>
		
		<dc:creator><![CDATA[NIPTadmin]]></dc:creator>
		<pubDate>Sun, 01 Dec 2019 02:07:40 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[China / Hong Kong]]></category>
		<category><![CDATA[CNVs]]></category>
		<category><![CDATA[Laboratory Performance / Laboratory Experience]]></category>
		<category><![CDATA[RAAs]]></category>
		<guid isPermaLink="false">https://niptconsortium.com/?p=9690</guid>

					<description><![CDATA[<p>Yu D, Zhang K, Han M, et al. Mol Genet Genomic Med. 2019;7(6):e674. doi:10.1002/mgg3.674. Open Access: Learn more Tags: Laboratory Performance / Laboratory Experience, 2019, China, RAAs, CNVs This publication reports on the development and evaluation of a low-pass whole genome sequencing assay for the detection of fetal CNVs and chromosomal aneuploidies in 20,003 pregnant [&#8230;]</p>
<p>The post <a href="https://niptconsortium.com/noninvasive-prenatal-testing-for-fetal-subchromosomal-copy-number-variations-and-chromosomal-aneuploidy-by-low-pass-whole-genome-sequencing/">Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Yu D, Zhang K, Han M, et al. Mol Genet Genomic Med. 2019;7(6):e674. doi:10.1002/mgg3.674. Open Access: <a href="https://onlinelibrary.wiley.com/doi/10.1002/mgg3.674" target="_blank" rel="noopener">Learn more</a></p>
<p><strong><em>Tags:</em></strong><em> Laboratory Performance / Laboratory Experience, 2019, China, RAAs, CNVs</em></p>
<ul>
<li>This publication reports on the development and evaluation of a low-pass whole genome sequencing assay for the detection of fetal CNVs and chromosomal aneuploidies in 20,003 pregnant women.</li>
</ul>
<p>The post <a href="https://niptconsortium.com/noninvasive-prenatal-testing-for-fetal-subchromosomal-copy-number-variations-and-chromosomal-aneuploidy-by-low-pass-whole-genome-sequencing/">Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes</title>
		<link>https://niptconsortium.com/clinical-utility-of-noninvasive-prenatal-screening-for-expanded-chromosome-disease-syndromes/</link>
		
		<dc:creator><![CDATA[NIPTadmin]]></dc:creator>
		<pubDate>Sun, 01 Sep 2019 02:08:12 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[China / Hong Kong]]></category>
		<category><![CDATA[Clinical Experience / Clinical Utility]]></category>
		<category><![CDATA[CNVs]]></category>
		<category><![CDATA[RAAs]]></category>
		<guid isPermaLink="false">https://niptconsortium.com/?p=9692</guid>

					<description><![CDATA[<p>Liang D, Cram DS, Tan H, et al. Genet Med. 2019;21(9):1998-2006. doi:10.1038/s41436-019-0467-4. Open Access: Learn more Tags: Clinical Experience / Clinical Utility, 2019, China, RAAs, CNVs This publication examined the clinical performance of Expanded NIPT for both aneuploidy and genome-wide microdeletion/microduplication syndromes in an all-risk pregnancy population. A cohort of 94,085 patients with singleton pregnancies [&#8230;]</p>
<p>The post <a href="https://niptconsortium.com/clinical-utility-of-noninvasive-prenatal-screening-for-expanded-chromosome-disease-syndromes/">Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Liang D, Cram DS, Tan H, et al. Genet Med. 2019;21(9):1998-2006. doi:10.1038/s41436-019-0467-4. Open Access: <a href="https://www.gimjournal.org/article/S1098-3600(21)05008-5/fulltext" target="_blank" rel="noopener">Learn more</a></p>
<p><strong><em>Tags:</em></strong><em> Clinical Experience / Clinical Utility, 2019, China, RAAs, CNVs</em></p>
<ul>
<li>This publication examined the clinical performance of Expanded NIPT for both aneuploidy and genome-wide microdeletion/microduplication syndromes in an all-risk pregnancy population. A cohort of 94,085 patients with singleton pregnancies were prospectively enrolled. This Expanded NIPT detected a clinically significant fetal chromosome abnormality in 1.2% of samples and calculated the respective PPVs for the screen positive abnormalities.</li>
</ul>
<p>The post <a href="https://niptconsortium.com/clinical-utility-of-noninvasive-prenatal-screening-for-expanded-chromosome-disease-syndromes/">Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies</title>
		<link>https://niptconsortium.com/non-invasive-prenatal-testing-to-detect-chromosome-aneuploidies-in-57204-pregnancies/</link>
		
		<dc:creator><![CDATA[NIPTadmin]]></dc:creator>
		<pubDate>Thu, 31 Jan 2019 02:08:50 +0000</pubDate>
				<category><![CDATA[2019]]></category>
		<category><![CDATA[China / Hong Kong]]></category>
		<category><![CDATA[Laboratory Performance / Laboratory Experience]]></category>
		<category><![CDATA[RAAs]]></category>
		<guid isPermaLink="false">https://niptconsortium.com/?p=9694</guid>

					<description><![CDATA[<p>Xue Y, Zhao G, Li H, et al. Mol Cytogenet. 2019;12:29. Published 2019 Jun 20. doi:10.1186/s13039-019-0441-5. Open Access: Learn more Tags: Laboratory Performance / Laboratory Experience, 2019, China, RAAs This publication retrospectively examined the performance of Expanded NIPT for all chromosome aneuploidies in 57,204 pregnancies from the Suzhou area of China and highlighted potential biological [&#8230;]</p>
<p>The post <a href="https://niptconsortium.com/non-invasive-prenatal-testing-to-detect-chromosome-aneuploidies-in-57204-pregnancies/">Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Xue Y, Zhao G, Li H, et al. Mol Cytogenet. 2019;12:29. Published 2019 Jun 20. doi:10.1186/s13039-019-0441-5. Open Access: <a href="https://molecularcytogenetics.biomedcentral.com/articles/10.1186/s13039-019-0441-5" target="_blank" rel="noopener">Learn more</a></p>
<p><strong><em>Tags:</em></strong><em> Laboratory Performance / Laboratory Experience, 2019, China, RAAs</em></p>
<ul>
<li>This publication retrospectively examined the performance of Expanded NIPT for all chromosome aneuploidies in 57,204 pregnancies from the Suzhou area of China and highlighted potential biological reasons for discordant results.</li>
</ul>
<p>The post <a href="https://niptconsortium.com/non-invasive-prenatal-testing-to-detect-chromosome-aneuploidies-in-57204-pregnancies/">Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
